Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Inflammation in Type 2 Diabetes
NCT01250340Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Aug 2010
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in type 2 diabetes mellitus (T2DM), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
aspirin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01250340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250340.